2024 mid-year myeloma review with paul richardson, md, dana farber cancer institute
Published 2 weeks ago • 446 plays • Length 1:09:44
Download video MP4
Download video MP3
Similar videos
-
1:04:18
multiple myeloma mid-year progress with dr. paul richardson of dana farber
-
1:28:01
myeloma crowd: paul richardson, md, dana farber cancer institute
-
1:28:28
mpatient myeloma radio: dr. paul richardson, md, dana-farber cancer institute
-
1:03:02
healthtree podcast for multiple myeloma: paul richardson, md, dana farber
-
8:06
mezigdomide (cc-92480) | paul richardson, md | ash 2022
-
2:39
ash23: paul richardson, md, discusses mezi trial | dana-farber cancer institute
-
7:32
myeloma determination study | paul richardson, md | ims 2022
-
1:25:40
diagnosed with high-risk myeloma: what now?
-
1:02:01
top myeloma research presented at asco & eha 2024
-
33:16
the future of myeloma care | new york roundtable october 19, 2024
-
2:47
mezigdomide plus dexamethasone in rrmm: cc-92480-mm-002 trial results| paul richardson, md |ash 2023
-
44:05
what are new treatment options for newly-diagnosed multiple myeloma patients? dr. paul g. richardson
-
5:29
new criteria for defining high risk multiple myeloma | gareth morgan & faith davies | ims 2024
-
26:59
multiple myeloma: open forum q&a | dana-farber cancer institute
-
35:50
dr. paul richardson on novel approaches for treating multiple myeloma | dana-farber cancer institute
-
1:37
the status quo is not enough: dr. paul richardson | dana-farber cancer institute
-
7:26
treatment options for frail patients at early relapse | paul richardson, md | ims 2023
-
6:17
ash impact series: paul richardson, md - examining the new fda approved myeloma drug products
-
4:00
os with cilta-cel vs soc in lenalidomide refractory mm | maría-victoria mateos, md, phd | ims 2024
-
1:15:33
the 2024 myeloma landscape with robert orlowski, md, phd, md anderson
-
57:14
multiple myeloma symposium: future of treatment | dana-farber cancer institute
Clip.africa.com - Privacy-policy